Patents by Inventor Aubrie Harland

Aubrie Harland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aryl Sulfonyl (Hydroxy) Piperidines as CCR6 Inhibitors
    Publication number: 20230133406
    Abstract: Compounds of formula (A) are provided which are useful in the treatment of diseases or conditions modulated at least in part by CCR6:
    Type: Application
    Filed: August 17, 2022
    Publication date: May 4, 2023
    Inventors: Penglie ZHANG, Daniel R. MARSHALL, Howard S. ROTH, Aubrie HARLAND, Ju YANG, Christopher W. LANGE, Rebecca M. LUI, Antoni KRASINSKI
  • Aryl Sulfonyl Compounds as CCR6 Inhibitors
    Publication number: 20230125684
    Abstract: Compounds of formula (I) are provided which are useful in the treatment of diseases or conditions modulated at least in part by CCR6:
    Type: Application
    Filed: August 17, 2022
    Publication date: April 27, 2023
    Inventors: Penglie ZHANG, Daniel R. MARSHALL, Howard S. ROTH, Aubrie HARLAND
  • Peptidomimetics and methods of using the same
    Patent number: 10519114
    Abstract: Disclosed herein are compounds useful for modulating the mu-opioid receptor (“MOR”) and/or delta-opioid receptor (“DOR”), and methods of using these compounds to treat diseases and conditions, such as pain. In particular, disclosed herein are compounds of Formula (I) and pharmaceutically acceptable salt thereof: wherein the substituents are as described.
    Type: Grant
    Filed: September 15, 2017
    Date of Patent: December 31, 2019
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Henry Mosberg, Deanna Montgomery, Aaron Bender, Anthony Nastase, Sean Henry, Aubrie Harland
  • Peptidomimetics and Methods of Using the Same
    Publication number: 20180072677
    Abstract: Disclosed herein are compounds useful for modulating the mu-opioid receptor (“MOR”) and/or delta-opioid receptor (“DOR”), and methods of using these compounds to treat diseases and conditions, such as pain. In particular, disclosed herein are compounds of Formula (I) and pharmaceutically acceptable salt thereof: wherein the substituents are as described.
    Type: Application
    Filed: September 15, 2017
    Publication date: March 15, 2018
    Inventors: Henry Mosberg, Deanna Montgomery, Aaron Bender, Anthony Nastase, Sean Henry, Aubrie Harland